The Federal Trade Commission has paused its suit against the nation’s biggest pharmacy benefit managers. States sue the Trump Administration after it abruptly cuts $11 billion in funding for public health initiatives. And, Eli Lilly says it is not affiliated with Hims & Hers after the telehealth company announces it will sell the drugmaker’s popular weight loss drug Zepbound. We’ll get those stories—and more—coming up on today’s episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
